Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway
Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway is a paper indexed in PICO Portal from OpenAlex.
How many citations does Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway have?
Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway has 60 citations in the OpenAlex counts PICO Portal stores.
When was Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway published?
Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway has 2021 year in the PICO Portal index.
What is the open-access status of Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway?
Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway has closed oa status in the PICO Portal index.
What is the DOI of Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway?
The DOI for Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway is on the source record.
What is the PMID of Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway?
The PMID for Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway is on the source record.
What is the OpenAlex record for Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway?
The OpenAlex for Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway is on the source record.